Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Healthcare Industry News Adaptive Biotechnologies sees stock surge after clonoSEQ EU certification In a major development for the biotechnology sector, Adaptive Biotechnologies Corporation witnessed a remarkable 29% surge in its… byPallavi MadhirajuSeptember 26, 2024